Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Pacific Biosciences of California (PACB) USD0.0001

Sell:$5.87 Buy:$5.88 Change: $0.01 (0.17%)
NASDAQ:0.27%
Market closed |  Prices as at close on 18 July 2019 | Switch to live prices |
Sell:$5.87
Buy:$5.88
Change: $0.01 (0.17%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed |  Prices as at close on 18 July 2019 | Switch to live prices |
Sell:$5.87
Buy:$5.88
Change: $0.01 (0.17%)
Market closed |  Prices as at close on 18 July 2019 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Contact details

Address:
1305 O'brien Drive
MENLO PARK
94025
United States
Telephone:
+1 (650) 5218000
Website:
www.pacificbiosciences.com.

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PACB
ISIN:
US69404D1081
Market cap:
$896.20 million
Shares in issue:
152.67 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Michael Hunkapiller
    Chairman of the Board, President, Chief Executive Officer
  • Susan Barnes
    Chief Financial Officer, Executive Vice President
  • James Phillips
    Senior Vice President - Research and Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.